Individual Risk Factors for Depression During GLP-1 Treatment Patients with a personal or family history of depression, bipolar disorder, or other mood disorders appear to carry higher risk for mood changes during GLP-1 therapy
Obesity and overweight are serious conditions that can be associated with some of the leading causes of death such as heart disease, stroke and diabetes, said John Sharretts, MD, director of the Division of Diabetes, Lipid Disorders and Obesity in the FDAs Center for Drug Evaluation and Research in an FDA press release announcing Zepbounds approval
The words of Tolkien are relevant to our quest to understand diabetic gastroparesis
Reducing sodium intake and increasing water consumption helps the body adapt within 2 to 4 weeks
SDS Safety and handling documents available for procurement review
Unlike injectable medications, the powder can be easily mixed into beverages or foods, making it a practical daily supplement